The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
Cancer research 2012 Nov 72 (22): 5683-91.
Serra Stefano, Zheng Lei, Hassan Manal, Phan Alexandria T, Woodhouse Linda J, Yao James C, Ezzat Shereen, Asa Sylvia
Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.
British journal of cancer 2007 Jun 96 (12): 1904-7.
Matakidou A, El Galta R, Rudd M F, Webb E L, Bridle H, Eisen T, Houlston R